Venture Capital Pulse — 2026-06-29
Q2 2026 marked a landmark quarter for startup exits, with more $1B+ liquidity events than any period since 2021, signaling strong momentum for later-stage investors. AI infrastructure and healthcare tech dominate fresh funding, while biotech rounds exceed $50M as VCs increasingly back proven, revenue-generating businesses. The week saw mixed signals: robust exit activity versus selective, quality-focused early-stage capital deployment.
Venture Capital Pulse — 2026-06-29
news.crunchbase.com
news.crunchbase.com
news.crunchbase.com
The $100M+ Round Is Now Just Your Typical Late-Stage Financing
The AI Startup Funding Boom Is Not A Global Phenomenon
The Week’s 10 Biggest Funding Rounds: World-Model Startup Odyssey Leads With $310M In Slower Week Fo
Top Deals This Week
XCures — $46M Series B
- Sector: Healthcare AI / Medical Records
- Lead investor(s): Innovius Capital
- What they do: AI platform for streamlining patient data and medical records management
- Why it matters: Reflects $8.5B in seed-to-growth AI health tech funding YTD; hospitals prioritizing operational efficiency and compliance
Lycia Therapeutics — $75M
- Sector: Biotech
- What they do: Drug development in protein degradation
- Why it matters: Part of record-breaking biotech funding wave; $50M+ rounds now routine
Oblenio — $62M
- Sector: Biotech
- What they do: Protein engineering and therapeutics
- Why it matters: Demonstrates sustained capital appetite for deep-tech biology
Seltz — $12.5M Seed
- Sector: AI / Search Infrastructure
- Lead investor(s): Speedinvest, Capital B
- What they do: Web search optimization platform for AI agents
- Why it matters: Founders from Amazon and Pinecone signal experienced operator focus in agent infrastructure space
Exits & Acquisitions
- Q2 2026 Record Billion-Dollar Exits: Crunchbase data shows Q2 2026 delivered the most startup exits valued at $1B+ since 2021, including the largest venture-backed exit of all time. The surge signals returning liquidity and validates 2021-era bets now maturing into exits.
Sector Spotlight
AI Infrastructure & Healthcare Tech Lead Capital Concentration
Over the past 12 months through Q1 2026, AI has captured $403.5B globally and $334.7B in the US alone, with the US over-indexing 1.98× versus the rest of the world. Healthcare AI, particularly medical records and operational workflow automation, has attracted $8.5B in seed-to-growth funding YTD.
This week's funding activity reinforces two clear trends:
- Production AI over demos: Capital gravitates toward systems making real decisions—patient routing, enterprise automation, agent-based search—rather than prototype-stage models
- Proven operators preferred: Founders with track records at Amazon, Pinecone, and other scaled companies now lead funding conversations; venture firms are tightening underwriting discipline post-2024 exuberance
The week's concentration in healthcare AI, biotech, and agent infrastructure reflects what Harvard Law's venture outlook termed a "selective, quality-driven environment" where VCs frontload capital to more mature, revenue-bearing startups.
What to Watch Next Week
- SpaceX IPO Aftermath: Founders Fund, Andreessen Horowitz, and Valor are the big VC winners from SpaceX's exit; watch for secondary follow-ons and space sector funding momentum.
- Mid-Year LP Commitments: Q1 2026 saw Carta funds raise $3.9B across 86 new funds; expect announcements of larger growth/buyout funds closing this summer.
- Healthcare M&A Pipeline: With $8.5B AI-health funding deployed, expect acquisition announcements as larger health systems and pharma integrate acquired data platforms.
- Defense Tech Capital Flow: Over $14.6B has flowed into defense/national security startups YTD (vs. $9.6B full year 2025); watch for late-stage rounds closing as geopolitical urgency drives allocations.
This content was collected, curated, and summarized entirely by AI — including how and what to gather. It may contain inaccuracies. Crew does not guarantee the accuracy of any information presented here. Always verify facts on your own before acting on them. Crew assumes no legal liability for any consequences arising from reliance on this content.
Powered by
